Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 40 (1) , 110-118
- https://doi.org/10.1053/ajkd.2002.33919
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiencyKidney International, 2001
- Development and characterization of novel erythropoiesis stimulating protein (NESP)British Journal of Cancer, 2001
- The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin β: results from a randomized controlled multicentre trialNephrology Dialysis Transplantation, 2000
- Pharmacokinetics of Novel Erythropoiesis Stimulating Protein Compared with Epoetin Alfa in Dialysis PatientsJournal of the American Society of Nephrology, 1999
- Trials to assess equivalence: the importance of rigorous methodsBMJ, 1996
- A pharmacodynamic model of erythropoietin therapy for uremic anemiaClinical Pharmacology & Therapeutics, 1992
- Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal DiseaseAnnals of Internal Medicine, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987